Sanctuary Advisors LLC Cuts Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sanctuary Advisors LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 4.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 62,163 shares of the medical equipment provider’s stock after selling 2,591 shares during the period. Sanctuary Advisors LLC’s holdings in Intuitive Surgical were worth $32,447,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in ISRG. Catalyst Capital Advisors LLC boosted its stake in shares of Intuitive Surgical by 132.5% in the 4th quarter. Catalyst Capital Advisors LLC now owns 637 shares of the medical equipment provider’s stock worth $332,000 after buying an additional 363 shares during the last quarter. AlphaCentric Advisors LLC boosted its stake in shares of Intuitive Surgical by 196.5% in the 4th quarter. AlphaCentric Advisors LLC now owns 3,706 shares of the medical equipment provider’s stock worth $1,934,000 after buying an additional 2,456 shares during the last quarter. Nicholas Hoffman & Company LLC. purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $241,000. Americana Partners LLC boosted its stake in shares of Intuitive Surgical by 6.5% in the 4th quarter. Americana Partners LLC now owns 3,667 shares of the medical equipment provider’s stock worth $1,914,000 after buying an additional 223 shares during the last quarter. Finally, Sierra Ocean LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $40,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on ISRG. Piper Sandler restated an “overweight” rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Truist Financial raised their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Evercore ISI raised their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Finally, CICC Research began coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

View Our Latest Analysis on ISRG

Insider Transactions at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Trading Up 0.7 %

Shares of ISRG stock opened at $595.55 on Monday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The stock’s 50-day moving average price is $559.48 and its 200-day moving average price is $519.66. The stock has a market capitalization of $212.12 billion, a price-to-earnings ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.